Casos de lesão hepática foram registrados em Victoria, Austrália, após o uso de produtos com retatrutida, substância para obesidade e diabetes. Autoridades suspeitam de contaminantes em versões ilegais comercializadas online.
Merz Pharma investiert über 100 Mio. Euro bis 2028 in den Standort Dessau-Roßlau, um Produktions-, Verpackungs- und Logistikkapazitäten auszubauen. CEO Philip Burchard bekräftigt das Vertrauen in den Industriestandort Deutschland angesichts gestiegener Nachfrage nach Neurotoxinen.
The US has initiated a Section 301 trade investigation into Germany's pharmaceutical pricing policies, alleging they unfairly burden US commerce and force the US to fund a disproportionate share of global drug R&D, potentially leading to new tariffs.
CVS is transitioning its over-the-counter medications to aluminum bottles, moving away from traditional plastic packaging. This change aims to improve sustainability and product stability, with initial conversions focusing on value-sized allergy and pain medications.
The U.S. has launched an investigation into Germany's pharma policies, citing "persistent underpayment" for medicines as Germany seeks to control rising healthcare costs. U.S. Trade Representative Jamieson Greer expressed concern over proposed legislation to reduce drug spending, calling it a "serious step backwards."
Die USA prüfen Deutschlands Pharmapolitik und drohen mit Zöllen. Grund: Die US-Regierung wirft Deutschland vor, durch niedrige Arzneimittelpreise die weltweiten Forschungs- und Entwicklungskosten unverhältnismäßig auf amerikanische Patienten abzuwälzen.
Zealand Pharma's stock dropped significantly due to high dropout rates for its weight loss drug survodutide. While survodutide's peak sales forecasts were cut, investors are now focusing on the company's amylin-based drug, petrelintide, as a potential future growth driver.
Zealand Pharma's stock dropped significantly due to high dropout rates for its weight loss drug survodutide. Investors are now focusing on its amylin-based drug, petrelintide, as the next potential growth driver, despite competition and previous efficacy concerns.
Die USA haben eine Handelsuntersuchung gegen Deutschland wegen der Preisgestaltung für Medikamente eingeleitet. Geprüft wird, ob Deutschland für innovative Pharmaprodukte zu wenig bezahlt.
Zealand Pharma's stock dropped significantly after survodutide showed high patient dropout rates. Investors are now focusing on its amylin-based drug, petrelintide, as a potential future driver, despite competition and previous efficacy concerns.
Indian drug giant Aurobindo Pharma has received final antitrust clearance from the US FTC for its takeover of Lannett Company. The acquisition, executed via its US subsidiary, is expected to close by the end of June, significantly expanding Aurobindo's US footprint.
The US has launched a Section 301 investigation into Germany concerning alleged underpayment for innovative pharmaceuticals, potentially impacting US commerce. Germany's proposed healthcare reforms and fast-tracking of legislation to reduce drug spending are key concerns.
The U.S. Federal Trade Commission (FTC) requires Aurobindo Pharma to sell four generic drug products to finalize its $250 million acquisition of Lannett Company Inc., preventing anti-competitive issues.
CVS is transitioning its over-the-counter (OTC) medications to aluminum bottles, moving away from traditional plastic packaging. This change aims to improve sustainability and practicality, with initial rollout on value-sized allergy and pain medications. Pricing remains unaffected, and customer response will determine wider adoption.
The European Parliament voted to pause parts of the EU's wastewater cleanup law, fearing that making drugmakers pay for micropollutant removal could lead to medicine shortages. Lawmakers approved suspending industry's obligation to pay for removing pollutants like antibiotics and microplastics, pending a new study on costs and sector blame.
UK health leaders warn of severe NHS medicine shortages, including painkillers and HRT, impacting patient safety and forcing some to skip meals. Supply chain issues, manufacturing disruptions, and budget constraints are cited as causes.
US-Pharmakonzern Moderna erwägt die Übernahme von BioNTech-Produktionsstätten in Deutschland, die das Unternehmen schließen will. Moderna-Chef Bancel führt Gespräche mit der Bundesregierung über eine Partnerschaft und fordert Planungssicherheit.
Cyber extortion group FulcrumSec claims to have stolen over 1TB of sensitive data from Novo Nordisk, including source code, drug information, and clinical trial data. The group allegedly demanded $25 million, which Novo Nordisk reportedly refused to pay. FulcrumSec is now reportedly exploring selling the stolen data.
Eine neue Reinigungsstufe in Klärwerken soll Arzneimittelrückstände und Schadstoffe aus dem Abwasser filtern. Die Industrie wehrt sich gegen die Kostenübernahme, was letztlich die Verbraucher treffen könnte.
Die Hackergruppe FulcrumSec fordert 25 Millionen Dollar Lösegeld vom Pharmakonzern Novo Nordisk, nachdem sie über ein Terabyte an Daten erbeutet hat. Das Unternehmen lehnte die Zahlung ab. Die Hacker drohen nun mit der Veröffentlichung oder dem Verkauf der gestohlenen Daten, darunter sensible Informationen zu Medikamenten und KI-Modellen.
Die Hackergruppe FulcrumSec fordert 25 Millionen Dollar Lösegeld vom Pharmakonzern Novo Nordisk, nachdem sie über ein Terabyte an Daten erbeutet hat. Das Unternehmen verweigert die Zahlung, und die Hacker drohen mit der Veröffentlichung oder dem Verkauf der gestohlenen Informationen, darunter sensible Medikamentendaten und KI-Modelle.
Europe's pharmaceutical sector faces decline due to geopolitical instability and lack of domestic support, falling behind the US and China in innovation, R&D, and clinical trials. Urgent action is needed to rebuild its ecosystem.
Cyberkriminelle der Gruppe FulcrumSec behaupten, über ein Terabyte an Daten von Novo Nordisk gestohlen zu haben, darunter Quellcodes und vertrauliche Medikamenteninformationen. Das Unternehmen bestätigte einen IT-Sicherheitsvorfall und verweigert eine Lösegeldzahlung von 25 Millionen Dollar.
Ministerpräsident Sven Schulze (CDU) kündigt einen "Zukunftspakt" an, um Sachsen-Anhalt als Pharmastandort zu stärken. Ein Fünf-Punkte-Plan soll Investitionen, Innovationen und Arbeitsplätze fördern, mit dem Ziel, das Land zu einem europäischen Top-Standort zu machen.
